Multi-Center Study to Evaluate the Efficacy and Safety of Sildenafil Cream (3.6%) in Premenopausal Patients With Female Sexual Arousal Disorder

NCT04948151 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

440

Enrollment

INDUSTRY

Sponsor class

Conditions

Female Sexual Arousal Disorder

Interventions

DRUG: Sildenafil
DRUG: Placebo

Sponsor

Strategic Science & Technologies, LLC

Collaborators

[object Object]